268 related articles for article (PubMed ID: 19304913)
1. PDE4 inhibitors roflumilast and rolipram augment PGE2 inhibition of TGF-{beta}1-stimulated fibroblasts.
Togo S; Liu X; Wang X; Sugiura H; Kamio K; Kawasaki S; Kobayashi T; Ertl RF; Ahn Y; Holz O; Magnussen H; Fredriksson K; Skold CM; Rennard SI
Am J Physiol Lung Cell Mol Physiol; 2009 Jun; 296(6):L959-69. PubMed ID: 19304913
[TBL] [Abstract][Full Text] [Related]
2. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4.
Michalski J; Kanaji N; Liu X; Nogel S; Wang X; Basma H; Nakanishi M; Sato T; Gunji Y; Fahrid M; Nelson A; Muller KC; Holz O; Magnussen H; Rabe KF; Toews ML; Rennard SI
Am J Respir Cell Mol Biol; 2012 Dec; 47(6):729-37. PubMed ID: 23043089
[TBL] [Abstract][Full Text] [Related]
4. PDE4 inhibitors attenuate fibroblast chemotaxis and contraction of native collagen gels.
Kohyama T; Liu X; Wen FQ; Zhu YK; Wang H; Kim HJ; Takizawa H; Cieslinski LB; Barnette MS; Rennard SI
Am J Respir Cell Mol Biol; 2002 Jun; 26(6):694-701. PubMed ID: 12034568
[TBL] [Abstract][Full Text] [Related]
5. Combination of roflumilast with a beta-2 adrenergic receptor agonist inhibits proinflammatory and profibrotic mediator release from human lung fibroblasts.
Tannheimer SL; Wright CD; Salmon M
Respir Res; 2012 Mar; 13(1):28. PubMed ID: 22452977
[TBL] [Abstract][Full Text] [Related]
6. A phosphodiesterase 4 inhibitor, roflumilast N-oxide, inhibits human lung fibroblast functions in vitro.
Sabatini F; Petecchia L; Boero S; Silvestri M; Klar J; Tenor H; Beume R; Hatzelmann A; Rossi GA
Pulm Pharmacol Ther; 2010 Aug; 23(4):283-91. PubMed ID: 20226872
[TBL] [Abstract][Full Text] [Related]
7. PDE4 inhibitor, roflumilast protects cardiomyocytes against NO-induced apoptosis via activation of PKA and Epac dual pathways.
Kwak HJ; Park KM; Choi HE; Chung KS; Lim HJ; Park HY
Cell Signal; 2008 May; 20(5):803-14. PubMed ID: 18276108
[TBL] [Abstract][Full Text] [Related]
8. A Novel, Pan-PDE Inhibitor Exerts Anti-Fibrotic Effects in Human Lung Fibroblasts via Inhibition of TGF-β Signaling and Activation of cAMP/PKA Signaling.
Wójcik-Pszczoła K; Chłoń-Rzepa G; Jankowska A; Ślusarczyk M; Ferdek PE; Kusiak AA; Świerczek A; Pociecha K; Koczurkiewicz-Adamczyk P; Wyska E; Pękala E; Gosens R
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503342
[TBL] [Abstract][Full Text] [Related]
9. Direct Inhibitory Effect of the PDE4 Inhibitor Roflumilast on Neutrophil Migration in Chronic Obstructive Pulmonary Disease.
Dunne AE; Kawamatawong T; Fenwick PS; Davies CM; Tullett H; Barnes PJ; Donnelly LE
Am J Respir Cell Mol Biol; 2019 Apr; 60(4):445-453. PubMed ID: 30395484
[TBL] [Abstract][Full Text] [Related]
10. A Nonhuman Primate PET Study: Measurement of Brain PDE4 Occupancy by Roflumilast Using (R)-[
Takano A; Uz T; Garcia-Segovia J; Tsai M; Lahu G; Amini N; Nakao R; Jia Z; Halldin C
Mol Imaging Biol; 2018 Aug; 20(4):615-622. PubMed ID: 29441434
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells.
Growcott EJ; Spink KG; Ren X; Afzal S; Banner KH; Wharton J
Respir Res; 2006 Jan; 7(1):9. PubMed ID: 16423283
[TBL] [Abstract][Full Text] [Related]
12. The differential impact of PDE4 subtypes in human lung fibroblasts on cytokine-induced proliferation and myofibroblast conversion.
Selige J; Hatzelmann A; Dunkern T
J Cell Physiol; 2011 Aug; 226(8):1970-80. PubMed ID: 21520048
[TBL] [Abstract][Full Text] [Related]
13. Modulation of matrix metalloproteinase production from human lung fibroblasts by type 4 phosphodiesterase inhibitors.
Martin-Chouly CA; Astier A; Jacob C; Pruniaux MP; Bertrand C; Lagente V
Life Sci; 2004 Jul; 75(7):823-40. PubMed ID: 15183075
[TBL] [Abstract][Full Text] [Related]
14. Cytokine-dependent balance of mitogenic effects in primary human lung fibroblasts related to cyclic AMP signaling and phosphodiesterase 4 inhibition.
Selige J; Tenor H; Hatzelmann A; Dunkern T
J Cell Physiol; 2010 May; 223(2):317-26. PubMed ID: 20082309
[TBL] [Abstract][Full Text] [Related]
15. Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4.
Kolosionek E; Savai R; Ghofrani HA; Weissmann N; Guenther A; Grimminger F; Seeger W; Banat GA; Schermuly RT; Pullamsetti SS
Mol Biol Cell; 2009 Nov; 20(22):4751-65. PubMed ID: 19759179
[TBL] [Abstract][Full Text] [Related]
16. The unrecognized effects of phosphodiesterase 4 on epithelial cells in pulmonary inflammation.
Konrad FM; Bury A; Schick MA; Ngamsri KC; Reutershan J
PLoS One; 2015; 10(4):e0121725. PubMed ID: 25909327
[TBL] [Abstract][Full Text] [Related]
17. Specific Features of Fibrotic Lung Fibroblasts Highly Sensitive to Fibrotic Processes Mediated via TGF-β-ERK5 Interaction.
Kadoya K; Togo S; Tulafu M; Namba Y; Iwai M; Watanabe J; Okabe T; Jin J; Kodama Y; Kitamura H; Ogura T; Kitamura N; Ikeo K; Takeda T; Kondo N; Takahashi K
Cell Physiol Biochem; 2019; 52(4):822-837. PubMed ID: 30946557
[TBL] [Abstract][Full Text] [Related]
18. Phosphodiestrase-1 and 4 inhibitors ameliorate liver fibrosis in rats: Modulation of cAMP/CREB/TLR4 inflammatory and fibrogenic pathways.
Essam RM; Ahmed LA; Abdelsalam RM; El-Khatib AS
Life Sci; 2019 Apr; 222():245-254. PubMed ID: 30858122
[TBL] [Abstract][Full Text] [Related]
19. A phosphodiesterase 4 inhibitor inhibits matrix protein deposition in airways in vitro.
Burgess JK; Oliver BG; Poniris MH; Ge Q; Boustany S; Cox N; Moir LM; Johnson PR; Black JL
J Allergy Clin Immunol; 2006 Sep; 118(3):649-57. PubMed ID: 16950284
[TBL] [Abstract][Full Text] [Related]
20. PGE 2 desensitizes β -agonist effect on human lung fibroblast-mediated collagen gel contraction through upregulating PDE4.
Fang Q; Ma Y; Wang J; Michalski J; Rennard SI; Liu X
Mediators Inflamm; 2013; 2013():145197. PubMed ID: 24227907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
